Table 1.
Antigen delivery system | Safety | Immunogenicity | Induction of innate immunity | Induction of adaptive immunity | Reference |
---|---|---|---|---|---|
(A) Live vaccines | |||||
Attenuated CyH-3 vaccine | Low | +++ | +++ | +++ | (2) |
Attenuated VHSV vaccine | Low | +++ | +++ | +++ | (3) |
Recombinant live virus protein | High | +++ | +++ | +++ | (4) |
(B) Inactivated vaccines | |||||
Inactivated whole pathogen | High | ++ | ++ | ++ | |
Subviral particle vaccines | High | + | + | + | (5) |
Subunit vaccines | High | + | + | + | (6) |
(C) Encapsulations/top dressing | |||||
PLGA nanoparticle vaccine | High | + | + | + | (7, 8) |
Chitosan nanoparticle vaccine | High | + | + | + | (9) |
PLGA microparticle vaccine | High | + | + | + | (10) |
Chitosan microparticle vaccine | High | + | + | + | (11) |
Alginate vaccines | High | + | + | + | (12) |
Micromatrix vaccines | High | + | + | + | (13) |